SCHEMBL10197491

SCHEMBL10197491

C/C(=N\NC(=O)c1cccc(C)c1)c1cccc(N=O)c1O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.54
SMN1; SMN2 Q16637 6/20 0.54
ALDH1A1 P00352 4/20 0.54
CYP1A2 P05177 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
MTOR P42345 5/20 0.47
RAB9A P51151 5/20 0.46
HTT P42858 3/20 0.46
KDM4E B2RXH2 2/20 0.46
KMT2A Q03164 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
MEN1 O00255 1/20 0.46
GAA P10253 1/20 0.46
PKM P14618 1/20 0.46
MCL1 Q07820 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
NPC1 O15118 4/20 0.46
LMNA P02545 1/20 0.46
POLB P06746 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL684697 0.84 MAPT (0.55) MAPTSMN1; SMN2ALDH1A1CYP1A2CYP2C9
SCHEMBL684707 0.83 RAB9A (0.58) MAPTSMN1; SMN2ALDH1A1CYP1A2CYP2C9
SCHEMBL683725 0.82 KDM1A (0.67) MAPTSMN1; SMN2ALDH1A1MTORRAB9A
SCHEMBL10053226 0.81 NPC1 (0.54) MAPTSMN1; SMN2ALDH1A1CYP1A2CYP2C19
SCHEMBL10053242 0.81 SMN1; SMN2 (0.58) MAPTSMN1; SMN2ALDH1A1CYP1A2CYP2C9
SCHEMBL683861 0.80 POLB (0.59) MAPTSMN1; SMN2ALDH1A1CYP1A2CYP2C9
SCHEMBL684595 0.80 MAPT (0.62) MAPTSMN1; SMN2ALDH1A1CYP1A2CYP2C9
SCHEMBL10197509 0.80 GAA (0.54) MAPTSMN1; SMN2ALDH1A1CYP1A2RAB9A
SCHEMBL30826072 0.77 SMN1; SMN2 (0.69) MAPTSMN1; SMN2ALDH1A1CYP1A2CYP2C9
SCHEMBL27178099 0.77 SMN1; SMN2 (0.69) MAPTSMN1; SMN2ALDH1A1CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120021066-A1 FUNGICIDAL COMPOSITIONS INCLUDING HYDRAZONE DERIVATIVES AND COPPER DOW AGROSCIENCES LLC (US) 2012-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120021066-A1 FUNGICIDAL COMPOSITIONS INCLUDING HYDRAZONE DERIVATIVES AND COPPER SOD1, CYP51A1, CYP4Z1 MAPT 921/4885SMN1; SMN2 3775/4885ALDH1A1 115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.